News Releases
Year: 2008 |2007 |2006 |2005 | 2004 | 2003
Dec 23, 2005Aspreva Pharmaceuticals Increases Revenue Guidance for Fiscal 2005
Nov 28, 2005 Nov 25, 2005 Nov 02, 2005Aspreva Pharmaceuticals Reports Third Quarter 2005 Results
Nov 01, 2005 Oct 31, 2005Aspreva Pharmaceuticals to Present at the CIBC World Markets Healthcare Conference in New York
Oct 24, 2005Aspreva to Release Third Quarter 2005 Financial Results on November 2nd
Sep 29, 2005Aspreva and Roche conclude Special Protocol Assessment and reach agreement with FDA
Sep 19, 2005Aspreva Pharmaceuticals to Present at the UBS Life Sciences Conference in New York
Sep 08, 2005 Sep 02, 2005Aspreva to Present at the BioCentury NewsMakers in the Biotech Industry Conference in New York
Aug 09, 2005Aspreva Pharmaceuticals Reports Second Quarter 2005 Results and Revises Guidance
Jul 28, 2005Aspreva to Release Second Quarter 2005 Financial Results on August 9th
Jul 27, 2005First Patient Treated in Aspreva Pivotal Phase III Lupus Nephritis Study
Jun 13, 2005Aspreva Pharmaceuticals to Present at the Merrill Lynch Canada 12th Annual Growth Stock Conference i
Jun 06, 2005Aspreva Pharmaceuticals to Present at Pacific Growth Equities 2005 Life Sciences Growth Conference
May 12, 2005Aspreva Pharmaceuticals Reports First Quarter 2005 Results and Provides Guidance
May 02, 2005Aspreva To Hold First Quarter 2005 Results Conference Call on May 12
Mar 09, 2005Aspreva Pharmaceuticals Announces Closing of IPO
Mar 03, 2005Aspreva Pharmaceuticals Announces Pricing of Initial Public Offering at US$11.00 (C$13.68) per Share
Jan 24, 2005Aspreva Pharmaceuticals Corporation Plans Initial Public Offering